Pharmaceutical manufacturers of Sulbactam sodium

Fresenius Kabi operates as an international healthcare organization specializing in essential medications and advanced technologies for intravenous therapy, blood transfusion, and medical nourishment. The company's portfolio is instrumental in supporting the needs of severely and persistently unwell individuals. Additionally, it provides a variety of active pharmaceutical ingredients (APIs) and finalized goods fabricated within its own establishments

Established in 1958, Qilu Pharmaceutical is now one of the leading vertically integrated pharmaceutical companies in China that develops, manufactures and distributes both Finished Dosage Forms (FDFs) and Active Pharmaceutical Ingredients (APIs). Qilu currently has 12 subsidiaries, 11 domestic manufacturing sites and over 3,9000 employees worldwide. Qilu ranks among Top 5 in Chinese pharmaceutical industry in 2022. Dedicated to offering high-quality & trustworthy medicines to the world and improving people‘s well-being, Qilu is vigorously exporting its products to over 100 countries and regions around the world.

ACS DOBFAR, an Italian firm established in 1973, is a privately owned business that serves as a fully integrated producer of Cephalosporin and Penicillin APIs as well as Finished Dosage Formulations. With manufacturing facilities located across the globe routinely examined by the US FDA, it stands as a prominent company among suppliers to the US market.

CSPC Pharmaceutical Group Limited ("CSPC") (Stock code: 1093.HK) is a leading pharmaceutical group in China. The Company has been listed on the Main Board of the Hong Kong Stock Exchange since 1994 and became a constituent stock of the Hang Sang Index in 2018 (the 1st constituent stock in the pharmaceutical sector since launch of the index). CSPC is currently also a constituent stock of the "Hang Seng Composite Index", "Hang Seng Healthcare Index", "Hang Seng SCHK Mainland China Healthcare Index", "Hang Seng Stock Connect Hong Kong Index", "Hang Seng China (Hong Kong-listed) 100 Index" and "Hang Seng China Enterprises Index". CSPC mainly owns two business segments of finished drugs and bulk drugs, with innovative drugs as the core development strategy. CSPC currently has a strong product portfolio in the therapeutic areas of nervous system disease, oncology, anti-infective and cardiovascular disease. Of which "NBP", "Domeisu", "Jinyouli", "Keaili" and "Xuanning" are the most popular innovative drug products in China. Bulk drug products include vitamin C, antibiotics and caffeine series. The manufacturing facilities of CSPC are mainly located in Shijiazhuang City, Hebei Province, China. CSPC has a international R&D team with R&D bases in Shijiazhuang, Shanghai, Beijing and the United States, focusing on the discovery, research and development of small molecule targeted drugs, nano-drugs, monoclonal antibody drugs, bispecific antibody drugs, antibody-drug conjugates and biological drugs in the immune field.

NCPC International Corp. is a platform for international trade of NCPC and the exclusive channel for exporting the preparations of NCPC, the business scope covers import and export trade, CMO, technology transfer and pharmaceutical logistics in domestic. NCPC International Corp. provides all-around and one-stop sales and service on APIs, preparations, medical equipments and consumables, based on creating more values for foreign customers. NCPC International Corp. has been exporting to more than 80 countries and regions, increasing the overseas sales yearly, ranking 1st on exporting preparations in china mainland for last continuous 3 years. NCPC International Corp. is a worldwide supplier of generic pharmaceuticals. As an Anti-infective expert and your local one- stop partner NCPC International Corp. will provide you the most comprehensive products and the most professional and efficient services. We are sincerely expecting to cooperate with friends from all sectors for shared development and a brighter future!

Nectar Lifesciences Limited is a research-driven, leading manufacturer of Active Pharmaceutical Ingredients (API), intermediates as well as Finished dosage forms offering largest segment of anti-infectives namely Cephalosporins. Nectar has proven to be a reliable CMO to global pharma innovators.

Zhuhai United has been ratedas "backbone enterprise inthe strategic emerging industriesof Guangdong Province" for many years in a row, and honored as one of the "Top 10 Export Enterprises of APIs in China", the "Best Enterprise of Medicine R&D Production Line in China" and with many other titles. Ranking the 21st among the top 100 enterprises of Chinese pharmaceutical industry and the 35th among the top 100 healthcare product import and export enterprises in China, it is also a "Pioneering Chinese Pharmaceutical Enterprise in Preparation Internationalization" and the "Most Popular 10 Listed Pharmaceutical Companies".

Reyoung Pharmaceutical Co., Ltd., established in 1966, is a modern comprehensive pharmaceutical company. Reyoung is given the title of National Trustworthy Company for Contract and Credit, Grade AAA Credit Company and Credit Company of Shandong Medical Industry. In the past 50 years, Reyoung inherits the mission “Reyoung Pharma., Benefit the public”, insists the business concept “Innovation is the basis, Product quality is first”. Never stop exploration and innovation, forging ahead with determination, and realizing the sustainable healthy development.

Established in the year 1987, Nakoda Chemicals Pvt. Ltd. is distinctively positioned ourselves as one of the renowned wholesalers, supplier, importer and traders of a quality approved range of Industrial and Agro Chemicals. Some of our offered products are Ammonium Bicarbonate, Ammonium Sulphate and Ammonium Chloride. Our provided products are formulated by using quality assured chemical compounds and contemporary technology. Our offered product range is highly demanded for its enhanced shelf life, precise pH value, precise composition and effective usage. These chemicals are cherished by our clients for their safe usage and for offering optimum results. Our products are procured from the authorized vendors, possessing huge experience in this domain. Furthermore, our trained professionals stringently inspect the products’ quality on different quality testing parameters at the time of procuring from the vendors till the final packaging of consignment. We make sure that the offered products are processed in a hygienic atmosphere so as to comply with the set standards of industry. We import our product from China.

SPC Research Institute of Food and BioTechnologyBusiness Integrity, SPC WAY encompasses the principles established by SPC to achieve its centennial as a worldwide enterprise. These principles are rooted in the Sangmidang Spirit and serve as the fundamental philosophy and compass for all SPC members. The Management Philosophy is the driving force behind SPC's existence. Through setting innovative challenges, SPC Group endeavors to delight customers with high-quality, nutritious, and delicious products.

IBI Istituto Biochimico Italiano G. Lorenzini S.p.A. operates as an autonomous pharmaceutical firm rooted in Italy, pioneering the development, manufacturing, and global promotion of medications since 1918. In line with our 'creating to contribute' mission, we have harnessed advanced technology to construct a range of products aimed at enhancing patients' well-being

Established in 1964 in Hong Kong, The United Laboratories Co Ltd is involved in the research and development, manufacturing, and sale of its products. TUL, a company listed in Hong Kong, operates six production bases with vertically integrated production. Its product range includes semi-synthetic penicillins, cephalosporins, β-lactamase inhibitor and blends, β-lactamase intermediates, APIs, and finished products.

Jiangxi Fushine Pharmaceutical Co., Ltd was founded in 2002, locating at a prestigious historic city and famous Millennium Porcelain Capital in China — Jingdezhen. Armed with advanced production equipments and manufacturing technologies, Fushine is specialized in the R & D, manufacture and sales of APIs and pharmaceutical intermediates. the company is a “National High-Technology Enterprise”, “Excellent Enterprise in Jiangxi Province”, Excellent Non-state-owned Enterprise in Jiangxi Province, Innovation-based Pilot Enterprise in Jiangxi Province”, and has set the “Provincial enterprise technology center”. The company has three wholly-owned subsidiaries including Jiangxi Xiangtai Pharmaceutical Co., Ltd etc. The company owns the key technology and currently is a main API manufacturer of β—lactamase inhibitors, and also the leading supplier of Carbapenem intermediates. Based on the advantages of production technology, quality management, EHS management and customer services, as well as the comprehensive and integrated risk management and control, our company enjoys a great reputation and cooperation with domestic and international customers, and our products are spread more than ten countries globally and regions in the globe.